Scribd
Upload
3K views2 pages

Resolution No. 2009-001

Resolution no. 2009-001

Uploaded by

Jerome Flojo
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
3K views2 pages

Resolution No. 2009-001

Resolution no. 2009-001

Uploaded by

Jerome Flojo
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 2

¢

“Republic of the Philippines


Department of Health
- OFFICE OF THE SECRETARY.
Bldg. No. 1, San Lazaro Compound, Rizal Avenue, Sta. Cruz, Manila 1003,
Tel. Nos, (632) 7411-95-02; 711-95-03; Telefax No. (632) 743-18-29

ADVISORY COUNCIL FOR PRICE REGULATION


RESOLUTION NO. 2009-004

IMPLEMENTING THE VOLUNTARY PRICE REDUCTION FOR AT LEAST SIXTEEN (16)


MOLECULES (OR 41 DRUG PREPARATIONS)

WHEREAS, access to affordable medicines for diseases of public health importance is


critical to improve the health and productivity of Filipinos, prevent impoverishment of
families
due to high cost of health care and thereby achieve the Millennium Development Goals and
National Objectives for Health:

WHEREAS, Republic Act $502 otherwise known as “The Universally Accessible Cheaper
and Quality Medicines Act of 2008" under Chapter 3 Section 17 and its implementing rules
and requiations provide that the President of the Philippines, upon recommendation of the
Secretary of the Departmnent of Health, shall have the power to impose Maximum Drug
Retall Prices (MRP) over any or all drugs and medicines as enumerated and provided for
within the Law

WHEREAS, as an outcome of the July 8, 2009 meeting of the President of the Philippines
with the representatives of the various multinational pharmaceutical companies, wherein Her
Excellency directed thasa companies to submit their voluntary compliance Letter of
Undertaking (LOU) within ten (10) days. 16 molecules (SKUs/preparations} from 8 innovator
companies and 1 local distributor (for products with no innovators locally}, have complied in
lowering the prices by 50%. upon submission of affected companies of their LOUs within the
prescribed period;

WHEREAS, Millennium Develapment Goal No. 8 aims ta develop a global partnership for
development, specifically Target 4 ln cooperation with pharmaceutical companies, provide
access to alfardable essential drugs in developing countries;
NOW WHEREFORE, in. order to implement voluntary reduction commitments by
pharmaceutical companies starting August 15, 2009, the Advisory Council endorses the
following agreements for the Secretary of Health's approval:

1. Manufacturers/distributors shall be voluntarily reducing prices of 16 molecules by


50% come August 15, 2009.
2. A letter of assurance shall be given by companies to drugstores for price adjustment
to enforce said reduction,
3. The drugstores shall reflect this voluntary 50% price reduction starting August 15,
2009.
4. The Bureau of Food and Drugs (BFAD) shall formulate an Administrative Order that
will reflect penalties and sanctions to vialators of this agreernent.
®. For small and medium sized drugstores that have manual systems and where said
price reduction is impossible to implement by August 15, 2009, they should comply
on or before September 15, 2009. Failure to do so by this date will mean sanctions
may be imposed starting September 16, 2009 subject to the policies formulated in
this regard by the Bureau of Food and Drugs (BFAD).
Be it, resolved and approvedto. transmit. this. Advisory Council Resolution for the
approval of the Secretaryof Health.

__
Approved this 24th day of July, 2009 at the Department of Health, Sta, Cruz, Manila
. Signed :
ALEXANDER A. PADILLA
‘Assistant Secretary
:
Undersecretary for
Office of Policy Standards for Regulatory Cluster
Health Department of Trade and Industry (OTN

go
Depariment of Health (DOH)
hitlhe FT

teat.
DIR.
4 RITA TAN TACANDONG
Director IV Special Assistant
Bureau of Food and Drugs (BFAD) Office of Policy Standards for Regulatory Cluster
Department of
Health

aei
TION. }OLANDO A. UTISTA HON. REY B. AQUINO
Presidad
PITC tag,
(PPI)

REINER GLOOR
W.

Executive Director
Pharmaceutical Healthcare Association of the
Philippines (PHAP)

JOSEPHINE P. INOGENCIO
National President
Drugstores Association of Phiippines (DSA4P)
uP

BELINDA &:
bije
Toe co REY MELCHOR F. SANTOS
President President
Watson's Personal Care Stare
Philippine Medical Association (PMA}
ey

a
.

fo NORMITA usvesh/” ANGELITO MENDOZA


Presidents... Chairman
Philippine Pharmacists Association (PPhA} Ayos na Gamot sa Abot-Kayang Presyo Coalition
(AGAP}

JAMES AUSTE EDELIZA FPF.


HERNANDEZ
Executive Director Chair
Cancer Warriors Foundation (CWF) Cut the cost Cut the pain Network (3CPNet)

GIOVANNI S. VILLAFUERTE
Ow. ROB iE. P. SO, MD
Coalition for Health Advocacy & Transparency rogram Manager

yn
National Drug Policy-Pharmaceutical Mgmt. Unit
50), DOH

APPROVED BY:

aul COT, pud


I
af Heatth
E Ul, MD, MSc
[pecan

You might also like